|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01416532 |
|
Date of registration:
|
12/08/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of Subclinical COronary Atherosclerosis for Risk Stratification Using Coronary Computed Tomography (CT) Angiography
ESCORT |
|
Scientific title:
|
Prognostic Value of Coronary CT Angiography in Relation to Evaluation of Subclinical Coronary Atherosclerosis for Risk Stratification in Asymptomatic Individuals From ESCORT Study |
|
Date of first enrolment:
|
January 2006 |
|
Target sample size:
|
5000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01416532 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Eun Ju Chun, MD, PhD |
|
Address:
|
|
|
Telephone:
|
82-31-787-7618 |
|
Email:
|
drejchun@hanmail.net |
|
Affiliation:
|
|
|
|
Name:
|
Eun Ju Chun, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Seoul National University Bundang Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- asymptomatic subjects
- adults > 20 years
- subjects who underwent both calcium score and coronary CT angiography
Exclusion Criteria:
- typical or atypical chest pain
- subjects who underwent previous percutaneous coronary intervention
- serious comorbid conditions(i.e. malignancy)
- insufficient medical record
- poor image quality
Age minimum:
20 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary Atherosclerosis
|
|
Secondary ID(s)
|
|
B-1107-131-104
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|